New drug application
Kanuma Concentrate for Solution for Infusion 2mg/ml
18 November 2026
The summary report for this therapeutic product is available for download
Summary report for Kanuma
Active ingredient | Product Registrant | Approval date | Summary report |
|---|---|---|---|
Sebelipase alfa | AstraZeneca Singapore Pte Ltd | 30 September 2025 |
